[1]
Borowiec, A., Właszczuk, A., Olakowska, E. and Lewin-Kowalik, J. 2022. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Medicine and Pharmacy Reports. (Jun. 2022). DOI:https://doi.org/10.15386/mpr-2187.